219 related articles for article (PubMed ID: 18708628)
1. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.
Pallasch CP; Schulz A; Kutsch N; Schwamb J; Hagist S; Kashkar H; Ultsch A; Wickenhauser C; Hallek M; Wendtner CM
Blood; 2008 Nov; 112(10):4213-9. PubMed ID: 18708628
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the Fas-inhibitory molecule TOSO: a novel antiapoptotic factor in chronic lymphocytic leukemia.
Pallasch CP; Wendtner CM
Leuk Lymphoma; 2009 Mar; 50(3):498-501. PubMed ID: 19347734
[TBL] [Abstract][Full Text] [Related]
3. TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia.
Yi S; Yu Z; Zhou K; Wang Y; An G; Li Z; Zou D; Qi J; Zhao Y; Chan WC; Qiu L
Leuk Lymphoma; 2011 Jan; 52(1):72-8. PubMed ID: 21133733
[TBL] [Abstract][Full Text] [Related]
4. [Expression and prognostic significance of TOSO in CD19+ B cells from Chinese CLL patients].
Yu Z; Zhou KS; Li ZJ; Yi SH; Hao M; Li CH; Qi JY; Qiu LG
Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1371-4. PubMed ID: 21756805
[TBL] [Abstract][Full Text] [Related]
5. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
6. TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia.
Zhang YR; Yu Z; Xiong WJ; Liu XX; Liu HM; Cui R; Wang Q; Chen WM; Qiu LG; Yi SH
Chin Med J (Engl); 2020 Sep; 133(17):2090-2097. PubMed ID: 32784334
[TBL] [Abstract][Full Text] [Related]
7. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
[TBL] [Abstract][Full Text] [Related]
8. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
von Wenserski L; Schultheiß C; Bolz S; Schliffke S; Simnica D; Willscher E; Gerull H; Wolters-Eisfeld G; Riecken K; Fehse B; Altfeld M; Nollau P; Binder M
Leukemia; 2021 Apr; 35(4):1073-1086. PubMed ID: 32826957
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
10. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
[TBL] [Abstract][Full Text] [Related]
11. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
12. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
[TBL] [Abstract][Full Text] [Related]
13. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.
Mongini PK; Gupta R; Boyle E; Nieto J; Lee H; Stein J; Bandovic J; Stankovic T; Barrientos J; Kolitz JE; Allen SL; Rai K; Chu CC; Chiorazzi N
J Immunol; 2015 Aug; 195(3):901-23. PubMed ID: 26136429
[TBL] [Abstract][Full Text] [Related]
14. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.
Guarini A; Chiaretti S; Tavolaro S; Maggio R; Peragine N; Citarella F; Ricciardi MR; Santangelo S; Marinelli M; De Propris MS; Messina M; Mauro FR; Del Giudice I; Foà R
Blood; 2008 Aug; 112(3):782-92. PubMed ID: 18487510
[TBL] [Abstract][Full Text] [Related]
15. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
[TBL] [Abstract][Full Text] [Related]
16. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
[TBL] [Abstract][Full Text] [Related]
17. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
18. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.
Kienle D; Benner A; Kröber A; Winkler D; Mertens D; Bühler A; Seiler T; Jäger U; Lichter P; Döhner H; Stilgenbauer S
Blood; 2006 Mar; 107(5):2090-3. PubMed ID: 16322480
[TBL] [Abstract][Full Text] [Related]
19. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients.
Hancer VS; Diz-Kucukkaya R; Aktan M
Med Oncol; 2012 Jun; 29(2):1068-72. PubMed ID: 21264533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
